| European Case Law Identifier: | ECLI:EP:BA:1996:J001792.19961122 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 22 November 1996 | ||||||||
| Case number: | J 0017/92 | ||||||||
| Application number: | 88118242.2 | ||||||||
| IPC class: | C07D 239/90 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Substituted quinazolinones as anticancer agents | ||||||||
| Applicant name: | WARNER-LAMBERT Company | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.1.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Consolidation permissible Substantial procedural violation (yes) Reimbursement of appeal fee equitable |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/j920017eu1.html
Date retrieved: 17 May 2021